Tüm alıştırma soruları

Soru 4481Soru →

A $45$ -year-old man is brought to the emergency department by his sister due to altered mental status. She states that he has a history of alcohol use disorder and was found confused in his apartment with an empty bottle of antifreeze nearby. Laboratory studies show:

Lab	Value
Serum sodium	$140 \text{ mEq/L}$
Serum potassium	$4.0 \text{ mEq/L}$
Serum chloride	$102 \text{ mEq/L}$
Serum bicarbonate	$12 \text{ mEq/L}$
Blood urea nitrogen (BUN)	$28 \text{ mg/dL}$
Serum glucose	$180 \text{ mg/dL}$
Measured serum osmolality	$325 \text{ mOsm/kg H}_2\text{O}$

Based on these laboratory results, what is this patient's calculated osmolar gap? (Provide the exact numerical value)

Cevabı ve açıklamayı göster

Cevap: 25

Cevap

The calculated osmolar gap is 25.

The patient has an elevated measured osmolality due to the ingestion of ethylene glycol (antifreeze). The calculated osmolality is

300 \text{ mOsm/kg H}_2\text{O}

, derived from the formula

2 \times \text{Na}^+ + \frac{\text{Glucose}}{18} + \frac{\text{BUN}}{2.8}

. Subtracting this calculated value from the measured osmolality of

325 \text{ mOsm/kg H}_2\text{O}

gives an osmolar gap of

25

. An elevated osmolar gap is a hallmark of toxic alcohol ingestion.

Adım Adım Çözüm

1

Calculate the estimated serum osmolality using the standard formula.

Calculated Osmolality =

2 \times 140 + \frac{180}{18} + \frac{28}{2.8} = 280 + 10 + 10 = 300 \text{ mOsm/kg H}_2\text{O}

.

The osmolar gap is the difference between measured and calculated osmolality. To find the gap, the calculated osmolality must first be determined from serum sodium, glucose, and BUN.

2

Subtract the calculated osmolality from the measured osmolality.

325 - 300 = 25

.

This yields the osmolar gap, which represents the presence of unmeasured osmotically active substances (in this case, ethylene glycol from antifreeze).

Anahtar Kavram

The osmolar gap is calculated by subtracting the calculated serum osmolality (

2 \times \text{Na}^+ + \frac{\text{Glucose}}{18} + \frac{\text{BUN}}{2.8}

) from the measured serum osmolality. An elevated osmolar gap (

>10 \text{ mOsm/kg H}_2\text{O}

) typically indicates the presence of toxic alcohols.

Tahmini Süre:1m 0s

Soru 4482Soru →

A 45-year-old woman is evaluated in the intensive care unit on the second day of induction chemotherapy for newly diagnosed high-grade Burkitt lymphoma. Over the past 8 hours, her urine output has significantly decreased. She reports mild nausea and generalized weakness. Her temperature is $37.1^\circ\text{C}$ ( $98.8^\circ\text{F}$ ), blood pressure is $110/70\text{ mmHg}$ , and pulse is $88/\text{min}$ . A stat laboratory panel shows the following results:

Laboratory Test	Result	Reference Range
Potassium	$6.8\text{ mEq/L}$	$3.5-5.0\text{ mEq/L}$
Calcium	$6.9\text{ mg/dL}$	$8.4-10.2\text{ mg/dL}$
Phosphorus	$7.8\text{ mg/dL}$	$2.5-4.5\text{ mg/dL}$
Uric acid	$14.2\text{ mg/dL}$	$2.4-6.0\text{ mg/dL}$
Creatinine	$2.6\text{ mg/dL}$	$0.6-1.1\text{ mg/dL}$

An electrocardiogram (ECG) reveals tall, peaked T waves with a shortened QT interval. Which of the following is the most appropriate next step in the management of this patient?

Administer intravenous calcium gluconate

Administer intravenous rasburicase

Initiate emergency hemodialysis

Administer intravenous sodium bicarbonate

Administer broad-spectrum intravenous antibiotics

Cevabı ve açıklamayı göster

Cevap: Administer intravenous calcium gluconate

Cevap

Administer intravenous calcium gluconate

The correct answer is to administer intravenous calcium gluconate. This patient has classic Tumor Lysis Syndrome (TLS), an oncologic emergency characterized by the massive release of intracellular contents following chemotherapy. The most immediately life-threatening complication of TLS is severe hyperkalemia, which this patient has developed along with concerning ECG changes (peaked T waves). In any patient with severe hyperkalemia and associated ECG abnormalities, the absolute first step in management is to stabilize the myocardial cell membrane with intravenous calcium (gluconate or chloride) to prevent fatal ventricular arrhythmias. Once the myocardium is stabilized, subsequent therapies can be initiated to shift potassium intracellularly (e.g., insulin and glucose) and remove it from the body, alongside targeted TLS treatments like rasburicase.

Adım Adım Çözüm

1

Identify the underlying clinical syndrome based on the presentation and labs.

The patient has Tumor Lysis Syndrome (TLS) characterized by hyperuricemia, hyperkalemia, hyperphosphatemia, hypocalcemia, and acute kidney injury following chemotherapy for a rapidly proliferating lymphoma.

Recognizing TLS provides the necessary context for anticipating severe metabolic derangements.

2

Prioritize the laboratory abnormalities to identify the most immediate threat to the patient's life.

The most dangerous abnormality is the severe hyperkalemia (

6.8\text{ mEq/L}

) with corresponding ECG changes (peaked T waves).

Hyperkalemia with ECG changes indicates imminent risk of lethal ventricular arrhythmias and cardiac arrest.

3

Determine the most rapid and effective intervention for the primary threat.

Intravenous calcium gluconate must be administered immediately.

Calcium directly antagonizes the effects of potassium on the myocardial cell membrane, providing instant cardioprotection while other therapies to lower serum potassium and uric acid are prepared.

Anahtar Kavram

In Tumor Lysis Syndrome complicated by severe hyperkalemia with ECG changes, immediate myocardial membrane stabilization with intravenous calcium is the paramount first step in management.

Tahmini Süre:1m 15s

Soru 4483Soru →

A 74-year-old man is evaluated in the surgical telemetry unit on postoperative day 4 following an open cholecystectomy and common bile duct exploration. The nursing staff requested a review because his urine output has decreased to $250 \text{ mL}$ over the last 24 hours, and he has become increasingly confused and short of breath. His medical history includes hypertension, type 2 diabetes mellitus, and a 40-pack-year smoking history. Temperature is $37.6^\circ\text{C}$ ( $99.7^\circ\text{F}$ ), blood pressure is $155/92 \text{ mm Hg}$ , pulse is $112/\text{min}$ , and respirations are $26/\text{min}$ . Oxygen saturation is $88\%$ on room air. Physical examination shows jugular venous distention $10 \text{ cm}$ above the sternal angle. Auscultation of the lungs reveals bilateral basilar crackles. The abdomen is soft and non-tender, with intact surgical staples and no erythema. Bilateral $2+$ pitting edema is present in the lower extremities.

Laboratory studies show:
Serum sodium: $134 \text{ mEq/L}$
Serum potassium: $5.2 \text{ mEq/L}$
Serum chloride: $98 \text{ mEq/L}$
Serum bicarbonate: $14 \text{ mEq/L}$
Blood urea nitrogen: $68 \text{ mg/dL}$
Serum creatinine: $3.1 \text{ mg/dL}$ (baseline $1.1 \text{ mg/dL}$ )

Arterial blood gas (room air):
pH: $7.24$
PaCO2: $42 \text{ mm Hg}$
PaO2: $58 \text{ mm Hg}$

Which of the following is the most accurate characterization of this patient's acid-base status and the most appropriate next step in management?

Mixed high anion gap metabolic acidosis and respiratory acidosis; administer intravenous furosemide

Uncompensated primary high anion gap metabolic acidosis; initiate urgent hemodialysis

Mixed high anion gap metabolic acidosis and respiratory alkalosis; administer intravenous normal saline

Primary respiratory acidosis with metabolic compensation; administer nebulized albuterol and ipratropium

Mixed high anion gap metabolic acidosis and respiratory acidosis; administer intravenous piperacillin-tazobactam

Cevabı ve açıklamayı göster

Cevap: Mixed high anion gap metabolic acidosis and respiratory acidosis; administer intravenous furosemide

Cevap

Mixed high anion gap metabolic acidosis and respiratory acidosis; administer intravenous furosemide

This patient presents with acute kidney injury, severe volume overload, and a complex acid-base derangement. The low pH (

7.24

) and low serum bicarbonate (

14 \text{ mEq/L}

) establish a primary metabolic acidosis. The anion gap is elevated at

22

(

134 - (98 + 14)

), pointing to a high anion gap metabolic acidosis, likely from retention of unmeasured uremic acids due to his acute kidney injury. To determine if respiratory compensation is adequate, Winter's formula must be applied: Expected

\text{PaCO}_2 = 1.5 \times [\text{HCO}_3^-] + 8 \pm 2

. For a bicarbonate of

14 \text{ mEq/L}

, the expected

\text{PaCO}_2

is

27

to

31 \text{ mm Hg}

. The patient's actual

\text{PaCO}_2

is

42 \text{ mm Hg}

, which is inappropriately high, indicating a concurrent primary respiratory acidosis. Clinically, this patient is in acute decompensated heart failure (ADHF) with pulmonary edema (crackles, hypoxia) and cardiorenal syndrome. The pulmonary edema impairs gas exchange, leading to

\text{CO}_2

retention and respiratory acidosis. The most appropriate immediate management for ADHF with pulmonary edema and cardiorenal acute kidney injury is diuresis with intravenous furosemide to decrease preload, relieve pulmonary congestion, and improve renal hemodynamics.

Adım Adım Çözüm

1

Identify the primary acid-base disorder using pH and bicarbonate levels.

The pH is 7.24 (acidemia) and serum bicarbonate is 14 mEq/L (low), indicating a primary metabolic acidosis.

Establishing the primary disturbance is required to determine the direction of the expected compensatory response.

2

Calculate the serum anion gap.

Anion Gap = Na - (Cl + HCO3) = 134 - (98 + 14) = 22 mEq/L. This is a high anion gap metabolic acidosis.

Differentiating between normal and high anion gap acidosis narrows the differential diagnosis (in this case, uremia from acute kidney injury).

3

Calculate the expected respiratory compensation using Winter's formula.

Expected PaCO2 = (1.5 x 14) + 8 = 29 (range 27-31 mm Hg).

Winter's formula determines if the pulmonary response to metabolic acidosis is appropriate or if a secondary respiratory disorder exists.

4

Compare the actual PaCO2 to the expected PaCO2.

The actual PaCO2 is 42 mm Hg, which is significantly higher than the expected range (27-31 mm Hg), confirming a superimposed primary respiratory acidosis.

An inappropriately elevated PaCO2 in the setting of metabolic acidosis indicates a mixed disorder (metabolic acidosis + respiratory acidosis).

5

Integrate clinical findings to determine the underlying etiology and next best step.

The patient exhibits signs of severe volume overload (hypertension, JVD, crackles, edema) causing cardiorenal syndrome (AKI) and pulmonary edema (respiratory acidosis). The correct intervention is intravenous furosemide.

Loop diuretics decrease preload, relieve pulmonary congestion, and can improve renal hemodynamics in acute decompensated heart failure.

Anahtar Kavram

Diagnosis of mixed acid-base disorders using Winter's formula and management of cardiorenal syndrome.

Tahmini Süre:2m 0s

Soru 4484Soru →

A 62-year-old man is evaluated in the intensive care unit on day 4 of an admission for severe urosepsis. He initially required mechanical ventilation and vasopressor support but is now hemodynamically stable and was extubated yesterday. He has a history of hypertension and benign prostatic hyperplasia. His medications include amlodipine, tamsulosin, and intravenous antibiotics. He has no history of thyroid disease. His temperature is 37.2°C (99.0°F), blood pressure is 118/76 mm Hg, and pulse is 82/min. Physical examination reveals clear lungs and a normal-sized, non-tender thyroid gland.

Laboratory studies show:

Test	Result	Reference Range
Thyroid-stimulating hormone (TSH)	1.1 µU/mL	0.4–4.0 µU/mL
Free thyroxine (T4)	1.2 ng/dL	0.9–1.7 ng/dL
Total triiodothyronine (T3)	50 ng/dL	80–200 ng/dL

Which of the following is the most likely mechanism responsible for this patient's thyroid laboratory findings?

Autoimmune destruction of thyroid follicular cells

Infarction of the anterior pituitary gland

Decreased peripheral conversion of thyroxine to triiodothyronine

Increased hepatic synthesis of thyroid-binding globulin

Release of preformed thyroid hormone from the gland

Cevabı ve açıklamayı göster

Cevap: Decreased peripheral conversion of thyroxine to triiodothyronine

Cevap

Decreased peripheral conversion of thyroxine to triiodothyronine (Euthyroid sick syndrome)

This patient's clinical picture of a severe systemic illness (urosepsis requiring ICU admission) combined with a low total T3, normal free T4, and normal TSH is classic for euthyroid sick syndrome, also known as non-thyroidal illness syndrome. In the setting of severe physiologic stress (such as sepsis, trauma, or prolonged starvation), the body decreases the activity of 5'-deiodinase, the enzyme responsible for the peripheral conversion of T4 (thyroxine) to the more active T3 (triiodothyronine). Concurrently, 5-deiodinase activity often increases, shunting T4 to the inactive metabolite reverse T3 (rT3). This is thought to be an adaptive mechanism to reduce metabolic rate and conserve energy during acute, severe illness. Thyroid hormone replacement is not indicated, and laboratory values typically normalize once the underlying illness resolves.

Adım Adım Çözüm

1

Evaluate the patient's clinical context.

The patient is recovering from a severe systemic illness (urosepsis requiring ICU admission).

Severe physiologic stress alters normal metabolic pathways, including thyroid hormone metabolism.

2

Interpret the thyroid function tests.

The patient has a normal TSH, normal free T4, and a selectively low total T3.

Identifying the specific pattern of thyroid laboratory abnormalities is required to determine the underlying etiology.

3

Synthesize the clinical history with the laboratory findings to identify the diagnosis and its mechanism.

The pattern of low T3 with normal T4 and TSH in an ICU patient confirms euthyroid sick syndrome (non-thyroidal illness syndrome), driven by decreased 5'-deiodinase activity.

During severe illness, the body adapts by reducing the conversion of prohormone (T4) to active hormone (T3) to conserve energy.

Anahtar Kavram

Euthyroid sick syndrome (non-thyroidal illness syndrome)

Soru 4485Soru →

Match each clinical presentation of an adverse drug effect with the most likely responsible antineoplastic or targeted therapy agent.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The correct matches are: Reversible LVEF decline with Trastuzumab; Hearing loss and renal injury with Cisplatin; Pleural effusions with Dasatinib; Acute cerebellar toxicity with Cytarabine; and Cold-induced neuropathy with Oxaliplatin.

Each antineoplastic agent has a well-defined toxicity profile. Trastuzumab causes reversible cardiotoxicity. Cisplatin causes ototoxicity and nephrotoxicity. Dasatinib can cause significant fluid retention, particularly pleural effusions. High-dose cytarabine causes cerebellar toxicity. Oxaliplatin causes acute cold-induced sensory neuropathy.

Adım Adım Çözüm

1

Evaluate the cardiac toxicity profile.

The asymptomatic, non-dose-dependent, and typically reversible LVEF decline points to Trastuzumab.

Differentiating Type I (anthracycline, dose-dependent, irreversible) from Type II (trastuzumab) cardiotoxicity is critical in oncology management.

2

Evaluate the ototoxicity and nephrotoxicity profile.

The combination of sensorineural hearing loss and rising creatinine points to Cisplatin.

Platinum-based alkylating-like agents have distinct toxicities; cisplatin is the most ototoxic and nephrotoxic of the group.

3

Evaluate the respiratory toxicity in CML.

Exudative pleural effusions in a patient on a tyrosine kinase inhibitor strongly point to Dasatinib.

While imatinib commonly causes periorbital edema, dasatinib specifically causes pleural effusions and pulmonary hypertension.

4

Evaluate the acute neurotoxicity in AML treatment.

Acute onset of nystagmus and ataxia during consolidation therapy identifies Cytarabine cerebellar toxicity.

High-dose regimens of cytarabine require routine neurological checks before each dose due to this specific risk.

5

Evaluate the peripheral neuropathy triggered by cold.

Cold-exacerbated dysesthesia and throat tightness identify Oxaliplatin.

Unlike the chronic stocking-glove neuropathy of vinca alkaloids or taxanes, oxaliplatin causes this unique acute cold-induced phenomenon.

Anahtar Kavram

Adverse effect profiles of antineoplastic agents

Tahmini Süre:1m 30s

Soru 4486Soru →

While evaluating a cohort of infants on the postnatal ward, a pediatrician encounters several characteristic dermatologic presentations. Match the specific clinical and cytological findings (1-4) with their appropriate benign neonatal dermatosis diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The correct matches pair the eosinophilic rash that spares palms/soles with Erythema toxicum neonatorum; the neutrophilic rash present at birth leaving pigmented macules with Transient neonatal pustular melanosis; the Malassezia-driven rash without comedones with Neonatal cephalic pustulosis; and the keratin retention cysts with Milia.

Each benign neonatal dermatosis has pathognomonic features: Erythema toxicum neonatorum is defined by an eosinophilic infiltrate and palmar/plantar sparing. Transient neonatal pustular melanosis is present at birth, leaves hyperpigmented macules, and shows a neutrophilic infiltrate. Neonatal cephalic pustulosis is driven by Malassezia and lacks comedones. Milia are distinct keratinous inclusion cysts.

Adım Adım Çözüm

1

Analyze the cellular infiltrate and anatomical distribution in the first description.

The presence of eosinophils and the specific sparing of the palms and soles identify erythema toxicum neonatorum.

Microscopic analysis of pustule fluid is the definitive way to differentiate this rash from similar appearing eruptions; eosinophils are pathognomonic here.

2

Evaluate the timing, progression, and cytology of the second description.

Lesions present strictly at delivery that leave hyperpigmented macules and contain neutrophils identify transient neonatal pustular melanosis.

Unlike erythema toxicum, this condition is present exactly at birth, involves neutrophils, and leaves a temporary residual pigmentation.

3

Identify the key negative clinical finding and etiology in the third description.

The absence of comedones combined with a facial distribution and Malassezia etiology distinguishes neonatal cephalic pustulosis.

True acne requires comedones; the neonatal variant is an inflammatory yeast reaction rather than a true acneiform disorder.

4

Assess the structural nature of the lesions in the fourth description.

Keratin-filled inclusion cysts clustered on the nose describe milia.

These are non-inflammatory anatomical retention cysts, differentiating them completely from the inflammatory pustular eruptions.

Anahtar Kavram

Differentiating benign neonatal skin lesions based on lesion morphology, age of onset, presence of comedones, and specific cytological findings (eosinophils vs. neutrophils).

Soru 4487Soru →

Emergency medical services bring a 68-year-old man to the hospital after his daughter found him lethargic and struggling to breathe. For the past 48 hours, he has experienced a fever and a worsening productive cough. His medical history is significant for severe chronic obstructive pulmonary disease (COPD), hypertension, and type 2 diabetes mellitus. His daily medications include tiotropium, lisinopril, and empagliflozin.

Vital signs are:
Temperature: 38.2°C (100.8°F)
Blood pressure: 110/65 mm Hg
Pulse: 118/min
Respirations: 26/min
Oxygen saturation: 86% on room air

Physical examination reveals a somnolent but arousable patient. Lung auscultation demonstrates diffuse wheezing and right lower lobe crackles with a prolonged expiratory phase.

Laboratory results are as follows:

Parameter	Result
Sodium	140 mEq/L
Potassium	4.6 mEq/L
Chloride	104 mEq/L
Bicarbonate	12 mEq/L
Blood urea nitrogen	32 mg/dL
Creatinine	1.4 mg/dL
Glucose	195 mg/dL
Albumin	4.0 g/dL

Arterial blood gas analysis on room air reveals:

Parameter	Result
pH	7.12
pCO $_2$	38 mm Hg
pO $_2$	56 mm Hg

Which of the following best characterizes this patient's acid-base status?

High anion gap metabolic acidosis with concurrent respiratory acidosis

High anion gap metabolic acidosis with appropriate respiratory compensation

High anion gap metabolic acidosis with concurrent respiratory alkalosis

Normal anion gap metabolic acidosis with concurrent respiratory acidosis

Mixed high and normal anion gap metabolic acidosis with appropriate respiratory compensation

Cevabı ve açıklamayı göster

Cevap: High anion gap metabolic acidosis with concurrent respiratory acidosis

Cevap

High anion gap metabolic acidosis with concurrent respiratory acidosis

This patient's acid-base status is evaluated in a stepwise fashion. First, the arterial pH is 7.12, indicating acidemia. The low serum bicarbonate (12 mEq/L) confirms a metabolic acidosis. Second, the anion gap must be calculated:

AG = Na^+ - (Cl^- + HCO_3^-) = 140 - (104 + 12) = 24

mEq/L. A normal anion gap is 10-14 mEq/L, so the patient has a high anion gap metabolic acidosis (HAGMA), which in this clinical scenario is likely secondary to sepsis or euglycemic diabetic ketoacidosis from empagliflozin use.

Next, to evaluate for mixed acid-base disorders, Winter's formula (

pCO_2 = 1.5 \times [HCO_3^-] + 8 \pm 2

) is used to determine the expected respiratory compensation. For this patient, the expected

pCO_2 = 1.5 \times 12 + 8 = 26 \pm 2

mm Hg. The patient's actual measured

pCO_2

is 38 mm Hg. Because the actual

pCO_2

is significantly higher than the expected range of 24-28 mm Hg, there is relative

CO_2

retention, confirming the presence of a concurrent primary respiratory acidosis. This is clinically consistent with a patient experiencing a COPD exacerbation and pneumonia, leading to respiratory fatigue and hypoventilation.

Adım Adım Çözüm

1

Calculate the anion gap to determine the primary metabolic disturbance.

AG =

Na^+ - (Cl^- + HCO_3^-) = 140 - (104 + 12) = 24

mEq/L.

An anion gap > 12 mEq/L confirms the presence of a high anion gap metabolic acidosis (HAGMA).

2

Apply Winter's formula to determine if respiratory compensation is appropriate.

Expected

pCO_2 = 1.5 \times [HCO_3^-] + 8 \pm 2 = 1.5 \times 12 + 8 \pm 2 = 26 \pm 2

mm Hg.

This establishes the target

pCO_2

range (24-28 mm Hg) the lungs should achieve to compensate for the metabolic acidosis.

3

Compare the actual

pCO_2

to the expected

pCO_2

calculated from Winter's formula.

The actual

pCO_2

is 38 mm Hg, which is > 28 mm Hg.

An actual

pCO_2

that is higher than the expected calculated range indicates a concurrent respiratory acidosis (relative

CO_2

retention).

Anahtar Kavram

In patients with metabolic acidosis, Winter's formula is essential to determine whether the respiratory response is adequate; an actual pCO2 higher than the expected range indicates a concurrent respiratory acidosis.

Soru 4488Soru →

A 34-year-old woman comes to the clinic for an annual health maintenance evaluation. She mentions feeling a bit fatigued lately but otherwise feels well. She has no history of neck radiation, surgery, or significant medical conditions. Her vital signs are within normal limits. Physical examination reveals a normal-sized thyroid gland without palpable nodules.

Laboratory studies are obtained with the following results:

Thyroid-stimulating hormone (TSH): $6.8 \text{ \mu U/mL}$ (Normal: $0.5 - 5.0 \text{ \mu U/mL}$ )
Free thyroxine (T4): $1.4 \text{ ng/dL}$ (Normal: $0.9 - 1.7 \text{ ng/dL}$ )

Which of the following is the most likely diagnosis?

Subclinical hyperthyroidism

Overt primary hypothyroidism

Subclinical hypothyroidism

Central hypothyroidism

Euthyroid sick syndrome

Cevabı ve açıklamayı göster

Cevap: Subclinical hypothyroidism

Cevap

Subclinical hypothyroidism

The correct diagnosis is subclinical hypothyroidism. This condition is biochemically defined by an elevated thyroid-stimulating hormone (TSH) level occurring alongside a normal serum free thyroxine (T4) level. Patients may be completely asymptomatic or have very mild, non-specific symptoms such as fatigue. In this vignette, the patient's TSH of

6.8 \text{ \mu U/mL}

is elevated, but her free T4 is clearly within normal limits, making this the only accurate diagnosis.

Adım Adım Çözüm

1

Evaluate the patient's Thyroid-stimulating hormone (TSH) level.

The TSH is elevated at

6.8 \text{ \mu U/mL}

.

TSH is the most sensitive initial screening test for primary thyroid dysfunction.

2

Evaluate the patient's Free thyroxine (T4) level.

The Free T4 is within the normal range at

1.4 \text{ ng/dL}

.

Free T4 distinguishes between overt and subclinical thyroid disease when TSH is abnormal.

3

Synthesize the laboratory findings to determine the diagnosis.

An elevated TSH paired with a normal Free T4 indicates a subclinical hypothyroid state.

The thyroid gland is producing adequate T4, but it requires higher-than-normal TSH stimulation from the pituitary to do so.

Anahtar Kavram

Subclinical hypothyroidism is defined biochemically by an elevated TSH level in the presence of a normal free T4 level.

Soru 4489Soru →

A 72-year-old man is brought to the emergency department by his daughter due to severe shortness of breath and an inability to lie flat in bed for the past $3$ days. He also reports a persistent nonproductive cough. His medical history is significant for chronic obstructive pulmonary disease (COPD), hypertension, stage 3 chronic kidney disease, and a nonfunctioning pituitary macroadenoma that was surgically resected $5$ years ago. His current medications include a daily tiotropium inhaler and amlodipine.

His temperature is $37.1^\circ$ C ( $98.8^\circ$ F), blood pressure is $165/95$ mm Hg, pulse is $102$ /min, and respiratory rate is $24$ /min. Pulse oximetry shows $88\%$ on room air. Physical examination reveals an elevated jugular venous pressure of $10$ cm H $_2$ O. Lung auscultation demonstrates bilateral crackles in the lower lung fields and a prolonged expiratory phase with scattered wheezes. Cardiac examination reveals a regular tachycardia and a prominent S $_3$ gallop. There is $2+$ pitting edema in the bilateral lower extremities.

Laboratory Study	Result	Reference Range
Leukocyte count	$7,500$ /mm $^3$	$4,000-11,000$ /mm $^3$
Serum sodium	$136$ mEq/L	$135-145$ mEq/L
Serum potassium	$4.2$ mEq/L	$3.5-5.0$ mEq/L
Serum bicarbonate	$18$ mEq/L	$22-28$ mEq/L
Blood urea nitrogen	$35$ mg/dL	$8-20$ mg/dL
Serum creatinine	$1.7$ mg/dL	$0.7-1.3$ mg/dL
Thyroid-stimulating hormone (TSH)	$1.5$ $\mu$ U/mL	$0.4-4.2$ $\mu$ U/mL
Free T4	$0.6$ ng/dL	$0.9-1.7$ ng/dL

Arterial Blood Gas (Room Air)	Result	Reference Range
pH	$7.37$	$7.35-7.45$
pCO $_2$	$32$ mm Hg	$35-45$ mm Hg
pO $_2$	$58$ mm Hg	$75-105$ mm Hg

A chest radiograph displays cardiomegaly, bilateral pleural effusions, and prominent interstitial markings without focal consolidation. Which of the following is the most appropriate next step in management for this patient?

Administer intravenous furosemide

Administer nebulized albuterol and systemic glucocorticoids

Initiate empiric piperacillin-tazobactam and vancomycin

Initiate levothyroxine supplementation

Administer intravenous sodium bicarbonate

Cevabı ve açıklamayı göster

Cevap: Administer intravenous furosemide

Cevap

The correct answer is to administer intravenous furosemide.

The patient's presentation of progressive orthopnea, elevated JVP, an S3 gallop, basilar crackles, and bilateral pitting edema is pathognomonic for acute decompensated heart failure (ADHF). The chest radiograph further supports this with cardiomegaly, pleural effusions, and interstitial edema. The most appropriate immediate next step in management is the administration of a loop diuretic, such as intravenous furosemide. This will rapidly decrease intravascular volume and right heart preload, which promptly relieves pulmonary congestion and improves the work of breathing.

Adım Adım Çözüm

1

Evaluate the clinical presentation and physical examination findings.

The patient has severe orthopnea, elevated jugular venous pressure, an S3 gallop, crackles, and peripheral edema.

These findings are hallmark signs of volume overload and acute decompensated heart failure (ADHF), overriding the diagnosis of a COPD exacerbation despite the presence of wheezing (cardiac asthma).

2

Analyze the laboratory and radiographic data to rule out competing diagnoses.

The chest radiograph confirms cardiomegaly and pulmonary edema without consolidation. The ABG shows a compensated metabolic acidosis with mild primary respiratory alkalosis, and thyroid labs show central hypothyroidism.

This confirms ADHF, rules out pneumonia (no consolidation/leukocytosis), and reveals underlying chronic issues that do not require immediate, life-saving acute intervention.

3

Select the most appropriate acute therapeutic intervention.

Intravenous furosemide is chosen.

Intravenous loop diuretics rapidly reduce intravascular volume and preload, quickly reversing pulmonary congestion and improving the patient's respiratory status.

Anahtar Kavram

Patients with acute decompensated heart failure can present with wheezing ('cardiac asthma'); management relies on rapid diuresis with intravenous loop diuretics, guided by signs of volume overload such as JVD, S3 gallop, and characteristic radiographic findings.

Tahmini Süre:1m 30s

Soru 4490Soru →

A 64-year-old woman is evaluated in the clinic following routine laboratory testing that revealed hypercalcemia. She has no symptoms of fatigue, abdominal pain, bone pain, or cognitive changes. Her medical history is significant for essential hypertension and osteopenia. Her medications include chlorthalidone and cholecalciferol. Blood pressure is 132/82 mm Hg, and pulse is 72/min. Physical examination is unremarkable.

Laboratory results are as follows:

Test	Result	Reference Range
Calcium	$11.2 \text{ mg/dL}$	$8.4-10.2 \text{ mg/dL}$
Phosphorus	$2.6 \text{ mg/dL}$	$2.5-4.5 \text{ mg/dL}$
Intact parathyroid hormone	$78 \text{ pg/mL}$	$15-65 \text{ pg/mL}$
25-hydroxyvitamin D	$36 \text{ ng/mL}$	$20-50 \text{ ng/mL}$
Creatinine	$0.8 \text{ mg/dL}$	$0.6-1.2 \text{ mg/dL}$
24-hour urine calcium	$85 \text{ mg}$	$100-300 \text{ mg}$
24-hour urine creatinine	$1000 \text{ mg}$	$800-1800 \text{ mg}$

The calculated calcium-to-creatinine clearance ratio is $0.006$ .

Which of the following is the most appropriate next step in management?

Discontinue chlorthalidone and repeat laboratory testing

Perform genetic testing for CASR mutations

Order technetium-99m sestamibi scintigraphy

Refer for surgical parathyroidectomy

Measure serum 1,25-dihydroxyvitamin D levels

Cevabı ve açıklamayı göster

Cevap: Discontinue chlorthalidone and repeat laboratory testing

Cevap

The most appropriate next step is to discontinue chlorthalidone and repeat the laboratory testing.

The most appropriate next step in management is to discontinue the thiazide diuretic (chlorthalidone) and repeat the laboratory testing in several weeks. This patient presents with PTH-dependent hypercalcemia (elevated serum calcium with an unsuppressed, elevated PTH). The primary differential for PTH-dependent hypercalcemia includes primary hyperparathyroidism, familial hypocalciuric hypercalcemia (FHH), and medication-induced hypercalcemia (e.g., lithium, thiazide diuretics). To differentiate between these, a 24-hour urine calcium and a calcium-to-creatinine clearance ratio (CCCR) are calculated. A CCCR of

< 0.01

indicates profound hypocalciuria. While this is the classic biochemical hallmark of FHH, thiazide diuretics act on the distal convoluted tubule to increase calcium reabsorption, producing an identical laboratory profile. Therefore, before pursuing genetic testing for FHH or evaluating for primary hyperparathyroidism, the confounding medication must be stopped, and the calcium profile reassessed to determine the true underlying physiology.

Adım Adım Çözüm

1

Analyze the serum calcium and intact PTH levels.

The patient has hypercalcemia (

11.2 \text{ mg/dL}

) with an inappropriately elevated PTH (

78 \text{ pg/mL}

).

This identifies the hypercalcemia as PTH-dependent, narrowing the differential to primary hyperparathyroidism, familial hypocalciuric hypercalcemia (FHH), and drug-induced causes.

2

Evaluate the 24-hour urine calcium and the calcium-to-creatinine clearance ratio (CCCR).

The 24-hour urine calcium is low (

85 \text{ mg}

) and the CCCR is

0.006

(

< 0.01

).

A CCCR

< 0.01

strongly suggests enhanced renal calcium reabsorption, which is characteristic of FHH or thiazide diuretic use, and makes primary hyperparathyroidism (typically CCCR

> 0.02

) highly unlikely.

3

Correlate the biochemical findings with the patient's medication list.

The patient is actively taking chlorthalidone, a thiazide diuretic.

Thiazides act on the distal convoluted tubule to decrease calcium excretion, producing an identical laboratory profile to FHH (mild hypercalcemia, high-normal or elevated PTH, and profound hypocalciuria).

4

Determine the most appropriate initial management step.

Discontinue the chlorthalidone and reassess.

The pharmacological confounder must be removed to establish an accurate baseline diagnosis before pursuing expensive genetic testing or invasive surgical evaluations.

Anahtar Kavram

Thiazide-induced hypercalcemia and its mimicry of Familial Hypocalciuric Hypercalcemia (FHH)

Soru 4491Soru →

An evaluation is requested for a 48-year-old male who is admitted to the intensive care unit with a 4-day history of coughing up blood-tinged sputum, progressive dyspnea, and passing dark red urine. Over the past six months, he has been treated three times for therapy-resistant maxillary sinusitis and chronic otitis media. Vital signs show a temperature of $37.6^\circ\text{C}$ ( $99.7^\circ\text{F}$ ), blood pressure of $165/95\text{ mm Hg}$ , heart rate of $110/\text{min}$ , and respiratory rate of $26/\text{min}$ . Oxygen saturation is $89\%$ on room air. Physical examination reveals ulceration of the nasal septum and bilateral coarse crackles in the lung fields. Laboratory results are as follows:

Test	Result	Reference Range
Serum creatinine	$2.8\text{ mg/dL}$	$0.6-1.2\text{ mg/dL}$
TSH	$1.2\text{ }\mu\text{U/mL}$	$0.5-5.0\text{ }\mu\text{U/mL}$
Free T4	$0.6\text{ ng/dL}$	$0.9-1.7\text{ ng/dL}$
Arterial pH	$7.24$	$7.35-7.45$
$\text{pCO}_2$	$24\text{ mm Hg}$	$35-45\text{ mm Hg}$
$\text{HCO}_3^-$	$10\text{ mEq/L}$	$22-28\text{ mEq/L}$

Urinalysis demonstrates $3+$ blood, $1+$ protein, $30-40$ dysmorphic red blood cells per high-power field, and occasional red blood cell casts. Chest radiography reveals diffuse bilateral alveolar opacities.

Which of the following is the most appropriate next step in the management of this patient?

Begin therapy with systemic glucocorticoids and rituximab

Administer broad-spectrum intravenous antibiotics

Administer intravenous sodium bicarbonate

Provide nebulized bronchodilators and ipratropium

Initiate daily oral levothyroxine supplementation

Cevabı ve açıklamayı göster

Cevap: Begin therapy with systemic glucocorticoids and rituximab

Cevap

Begin therapy with systemic glucocorticoids and rituximab

The correct next step is to begin therapy with systemic glucocorticoids and rituximab. This patient presents with the classic triad of Granulomatosis with polyangiitis (GPA): upper respiratory tract involvement (chronic sinusitis, otitis media, nasal septal ulceration), lower respiratory tract involvement (hemoptysis from diffuse alveolar hemorrhage), and renal involvement (rapidly progressive glomerulonephritis evidenced by acute kidney injury with dysmorphic RBCs and RBC casts). The simultaneous presence of acute alveolar hemorrhage and rapidly declining renal function is a life-threatening presentation known as pulmonary-renal syndrome. Immediate induction therapy with high-dose systemic glucocorticoids combined with an immunosuppressant (either rituximab or cyclophosphamide) is strictly required to halt progressive multi-organ destruction and preserve organ function.

Adım Adım Çözüm

1

Identify the primary triad of symptoms in the clinical vignette.

The patient has upper respiratory tract disease (chronic sinusitis, nasal septal ulceration), lower respiratory tract disease (hemoptysis, bilateral alveolar opacities), and renal disease (acute kidney injury with dysmorphic RBCs and RBC casts).

Recognizing this classic triad establishes the clinical diagnosis of Granulomatosis with polyangiitis (GPA), an ANCA-associated vasculitis.

2

Evaluate the severity of the patient's presentation.

The patient has diffuse alveolar hemorrhage causing hypoxemia and rapidly progressive glomerulonephritis.

This constellation is known as pulmonary-renal syndrome, which is a life-threatening medical emergency requiring immediate, aggressive intervention.

3

Select the appropriate pharmacological management based on the diagnosis and severity.

Induction therapy with high-dose systemic glucocorticoids combined with either rituximab or cyclophosphamide is chosen.

Aggressive immunosuppression is the standard of care to halt autoimmune tissue destruction, prevent irreversible renal failure, and resolve alveolar hemorrhage in severe GPA.

4

Rule out competing distractors by analyzing the remaining laboratory data.

The acid-base status represents a pure, appropriately compensated metabolic acidosis via Winter's formula (

1.5 \times 10 + 8 = 23 \pm 2

). The thyroid panel indicates euthyroid sick syndrome (low T4, normal TSH in critical illness).

Proper data interpretation confirms that sodium bicarbonate and levothyroxine are unindicated and incorrect management steps.

Anahtar Kavram

Patients with Granulomatosis with polyangiitis (GPA) presenting with life-threatening pulmonary-renal syndrome require emergent induction immunosuppressive therapy with high-dose systemic glucocorticoids and rituximab or cyclophosphamide.

Soru 4492Soru →

A $62$ -year-old man is hospitalized for the treatment of an acute right-sided pulmonary embolism. He is initially started on a continuous intravenous unfractionated heparin infusion. On hospital day 6, his platelet count is noted to have decreased from a baseline of $240,000/mm^3$ on admission to $90,000/mm^3$ . Concurrently, he reports new-onset left leg pain and swelling. Venous duplex ultrasonography reveals a new acute deep venous thrombosis in the left femoral vein. Heparin-induced thrombocytopenia is suspected. The heparin infusion is immediately discontinued, and intravenous argatroban is initiated. A serotonin release assay later returns positive, confirming the diagnosis. Four days later, the patient's leg swelling has significantly improved, and his respiratory status remains stable. His current platelet count is $115,000/mm^3$ . The patient is eager to transition to an oral anticoagulant and be discharged. Which of the following is the most appropriate next step in the management of this patient's anticoagulation?

Initiate warfarin therapy immediately and continue argatroban until the INR is therapeutic

Delay the initiation of warfarin until the platelet count recovers to at least

150,000/mm^3

Discontinue argatroban and initiate subcutaneous enoxaparin as a bridge to warfarin

Administer a pooled platelet transfusion to correct the thrombocytopenia, then initiate warfarin

Discontinue argatroban and initiate a prophylactic dose of subcutaneous fondaparinux

Cevabı ve açıklamayı göster

Cevap: Delay the initiation of warfarin until the platelet count recovers to at least $150,000/mm^3$

Cevap

Delay the initiation of warfarin until the platelet count recovers to at least 150,000/mm³.

The correct approach is to delay the initiation of warfarin until the patient's platelet count has recovered to at least

150,000/mm^3

. Heparin-induced thrombocytopenia (HIT) is a highly prothrombotic state caused by IgG autoantibodies against platelet factor 4 (PF4) complexed with heparin. These antibodies activate platelets, leading to consumptive thrombocytopenia and paradoxical thrombosis. When transitioning a patient with HIT to long-term oral anticoagulation with warfarin, timing is critical. Warfarin exerts its effect by inhibiting the vitamin K-dependent synthesis of procoagulant factors (II, VII, IX, and X) as well as the endogenous anticoagulant proteins C and S. Because protein C has a significantly shorter half-life (approximately 8 hours) than most procoagulant factors (e.g., factor II has a half-life of 60 hours), the initiation of warfarin creates a transient hypercoagulable window. If warfarin is started during the acute phase of HIT (while platelets are still low and the thrombotic drive is highest), this rapid depletion of protein C can lead to catastrophic microvascular thrombosis, classically presenting as venous limb gangrene or warfarin-induced skin necrosis. Therefore, a non-heparin parenteral anticoagulant (such as argatroban) must be continued alone until the acute phase has resolved, indicated by a platelet count recovery to

\geq 150,000/mm^3

. At that point, warfarin can be initiated with a minimum 5-day overlap with the parenteral agent until the INR is therapeutic.

Adım Adım Çözüm

1

Identify the patient's current clinical status.

The patient has confirmed heparin-induced thrombocytopenia (HIT) complicated by a new deep venous thrombosis, currently treated with argatroban. His platelet count is recovering but is still low at

115,000/mm^3

.

Establishing the current phase of HIT (acute vs. recovering) is necessary to guide the transition to long-term oral anticoagulation.

2

Determine the safety of initiating warfarin in the acute phase of HIT.

Warfarin cannot be safely initiated while the patient is still thrombocytopenic (platelets <

150,000/mm^3

).

Warfarin causes rapid depletion of the anticoagulant protein C before it depletes procoagulant factors. In the already highly prothrombotic state of HIT, this can precipitate venous limb gangrene.

3

Select the appropriate next step in management.

The initiation of warfarin must be delayed until the platelet count reaches at least

150,000/mm^3

.

Waiting for platelet recovery ensures the acute prothrombotic phase of HIT has resolved sufficiently to safely tolerate the transient protein C depletion caused by warfarin.

Anahtar Kavram

In patients with heparin-induced thrombocytopenia, warfarin initiation must be delayed until the platelet count recovers to at least 150,000/mm³ to prevent venous limb gangrene.

Soru 4493Soru →

A $34$ -year-old woman presents to the clinic for evaluation of a skin rash. She noticed the rash on her right posterior thigh $4$ days ago, and it has steadily increased in size. She recently returned from a camping trip in Maine. The patient reports mild fatigue and muscle aches but denies fever, joint swelling, or shortness of breath. Her temperature is $37.1^\circ\text{C}$ ( $98.8^\circ\text{F}$ ), blood pressure is $120/78\text{ mm Hg}$ , and pulse is $76\text{/min}$ . Physical examination reveals a $10\text{-cm}$ , annular, erythematous plaque with a central area of clearing on the right posterior thigh. The remainder of the examination is unremarkable. Which of the following is the most appropriate next step in management?

Prescribe oral doxycycline

Perform serologic testing for Borrelia burgdorferi

Prescribe intravenous ceftriaxone

Prescribe oral cephalexin

Prescribe topical hydrocortisone

Cevabı ve açıklamayı göster

Cevap: Prescribe oral doxycycline

Cevap

Prescribe oral doxycycline

The correct action is to prescribe oral doxycycline. This patient presents with a classic erythema migrans rash (annular, erythematous plaque with central clearing) and a history of recent travel to a Lyme-endemic area, which is diagnostic for early localized Lyme disease. In early localized disease, empiric treatment with an oral antibiotic (such as doxycycline, amoxicillin, or cefuroxime) should be initiated immediately based entirely on clinical findings.

Adım Adım Çözüm

1

Identify the primary clinical finding and its significance.

The patient has a large, expanding annular erythematous plaque with central clearing (erythema migrans) after visiting a Lyme-endemic area.

Erythema migrans is the hallmark physical finding of early localized Lyme disease.

2

Determine the appropriate diagnostic approach.

Diagnosis is made clinically based on the characteristic rash; serologic testing is unnecessary at this stage.

Antibodies to Borrelia burgdorferi often take weeks to develop, so serology has low sensitivity early in the disease course and can yield false-negative results.

3

Select the optimal management strategy.

Initiate empiric oral antibiotic therapy.

Oral doxycycline is the first-line treatment for early localized Lyme disease in non-pregnant adults.

Anahtar Kavram

Diagnosis and management of early localized Lyme disease

Soru 4494Soru →

An occupational health clinic evaluates a $31$ -year-old hospital pharmacist for a two-month history of irritability, frequent palpitations, and heat intolerance. She reports poor sleep and an unintentional $4\text{-kg}$ ( $8.8\text{-lb}$ ) weight loss during this period. The patient has no significant past medical history and takes no prescribed medications, although she admits to taking various over-the-counter "energy supplements" to help with long shifts. Her vital signs show a pulse of $112\text{/min}$ and a blood pressure of $138/82\text{ mm Hg}$ . Physical examination reveals a fine tremor of the outstretched hands and hyperactive deep tendon reflexes. The eyes show no proptosis, lid lag, or periorbital edema. The thyroid gland is not palpable, and there is no cervical lymphadenopathy or anterior neck tenderness.

Laboratory evaluation shows:
Thyroid-stimulating hormone (TSH): $<0.01\text{ }\mu\text{U/mL}$ (normal: $0.4$ - $4.0\text{ }\mu\text{U/mL}$ )
Free T4: $2.9\text{ ng/dL}$ (normal: $0.8$ - $1.8\text{ ng/dL}$ )
Free T3: $6.2\text{ pg/mL}$ (normal: $2.3$ - $4.2\text{ pg/mL}$ )

A subsequent $24$ -hour radioactive iodine uptake scan reveals $<1\%$ uptake (normal: $10\%$ - $30\%$ ).

Which of the following is the most appropriate next step in the diagnostic workup?

Measurement of serum thyroid-stimulating immunoglobulin

Measurement of erythrocyte sedimentation rate

Measurement of serum thyroglobulin

Ultrasound of the pelvis

Magnetic resonance imaging of the brain

Cevabı ve açıklamayı göster

Cevap: Measurement of serum thyroglobulin

Cevap

Measurement of serum thyroglobulin

This patient presents with clinical and biochemical evidence of primary thyrotoxicosis, confirmed by a suppressed TSH and elevated free T4 and free T3. The subsequent low radioactive iodine uptake (RAIU) indicates that her thyroid gland is not actively synthesizing new hormone. The differential diagnosis for thyrotoxicosis with a low RAIU includes destructive thyroiditis (such as painless or subacute thyroiditis), exogenous thyroid hormone intake (factitious thyrotoxicosis), and ectopic thyroid hormone production (such as struma ovarii). The complete lack of neck pain or tenderness effectively rules out subacute granulomatous thyroiditis. To definitively differentiate between painless thyroiditis (endogenous release of preformed hormone due to follicular destruction) and factitious thyrotoxicosis (exogenous hormone consumption), a serum thyroglobulin level is required. Thyroglobulin is a precursor protein that is co-released into the circulation along with endogenous thyroid hormones. Therefore, thyroglobulin levels will be elevated in destructive thyroiditis but suppressed in exogenous thyroid hormone abuse. Given the patient's profession as a pharmacist, providing access to medications, and her use of unnamed 'energy supplements', factitious thyrotoxicosis is highly suspected.

Adım Adım Çözüm

1

Interpret the initial thyroid function tests.

The patient has a suppressed TSH with elevated free T4 and free T3, confirming primary thyrotoxicosis.

Establishing the biochemical presence of primary thyrotoxicosis is the necessary first step before determining the underlying etiology.

2

Analyze the results of the radioactive iodine uptake (RAIU) scan.

The RAIU is <1%, indicating that the thyroid gland is not actively synthesizing new hormone.

A low RAIU differentiates thyrotoxicosis due to active endogenous overproduction (such as Graves disease or toxic adenoma) from conditions involving preformed hormone release or exogenous hormone intake.

3

Synthesize the clinical presentation with the low RAIU to narrow the differential diagnosis.

The absence of a tender goiter makes subacute (de Quervain) thyroiditis highly unlikely. The primary remaining differentials are painless (silent) thyroiditis and factitious thyrotoxicosis.

Clinical examination features (e.g., presence or absence of pain) help to quickly exclude inflammatory causes of a low RAIU.

4

Select the appropriate confirmatory test to distinguish exogenous from endogenous thyrotoxicosis.

Serum thyroglobulin should be measured.

Thyroglobulin is co-secreted with endogenous thyroid hormone. It is elevated in destructive thyroiditis but profoundly suppressed in factitious thyrotoxicosis due to the exogenous source of hormone suppressing normal glandular activity.

Anahtar Kavram

Patients presenting with thyrotoxicosis and a low radioactive iodine uptake (RAIU) should be evaluated with a serum thyroglobulin level to definitively differentiate between endogenous destructive thyroiditis (which features high thyroglobulin) and exogenous factitious thyrotoxicosis (which features low thyroglobulin).

Soru 4495Soru →

During morning rounds in the intensive care unit, the medical team evaluates a patient with septic shock secondary to a perforated viscus. The patient's arterial blood gas and basic metabolic panel are drawn to assess his acid-base status. The laboratory results reveal a severe primary metabolic acidosis with a serum bicarbonate level of $14 \text{ mEq/L}$ and a significantly elevated serum lactate. To determine if a superimposed respiratory acid-base disorder is present, the physician calculates the expected respiratory response. Assuming appropriate respiratory compensation, which of the following is the expected partial pressure of carbon dioxide ( $PaCO_2$ ) in this patient?

14 \text{ mm Hg}

21 \text{ mm Hg}

29 \text{ mm Hg}

35 \text{ mm Hg}

40 \text{ mm Hg}

Cevabı ve açıklamayı göster

Cevap: $29 \text{ mm Hg}$

Cevap

The expected

PaCO_2

is

29 \text{ mm Hg}

(with a normal physiological range of

\pm 2

), calculated using Winter's formula.

The correct expected value is

29 \text{ mm Hg}

. In primary metabolic acidosis, peripheral chemoreceptors sense the low pH and stimulate the respiratory center to increase ventilation. This compensatory hyperventilation blows off

CO_2

in an attempt to normalize the pH. The expected

PaCO_2

can be reliably calculated using Winter's formula: Expected

PaCO_2 = (1.5 \times [HCO_3^-]) + 8 \pm 2

. For a bicarbonate of

14 \text{ mEq/L}

, the calculation is

(1.5 \times 14) + 8 = 21 + 8 = 29

. The expected

PaCO_2

target is therefore

29 \text{ mm Hg}

(range

27

to

31 \text{ mm Hg}

). If the measured

PaCO_2

falls outside this range, a superimposed respiratory disorder is present.

Adım Adım Çözüm

1

Identify the primary acid-base disturbance.

Primary metabolic acidosis.

The patient has a low serum bicarbonate level (

14 \text{ mEq/L}

) driven by elevated lactate from septic shock.

2

Select the appropriate formula to calculate respiratory compensation.

Winter's formula: Expected

PaCO_2 = (1.5 \times [HCO_3^-]) + 8 \pm 2

.

This formula is specifically validated to determine the expected degree of hyperventilation (and resulting

PaCO_2

) in primary metabolic acidosis.

3

Calculate the expected value.

1.5 \times 14 + 8 = 21 + 8 = 29 \text{ mm Hg}

.

Plugging the patient's bicarbonate level into the formula yields the exact target central value.

Anahtar Kavram

Winter's formula (

1.5 \times [HCO_3^-] + 8 \pm 2

) is used to calculate the expected respiratory compensation (expected

PaCO_2

) in a patient with a primary metabolic acidosis.

Tahmini Süre:45s

Soru 4496Soru →

An 82-year-old man with advanced Alzheimer dementia is brought to the emergency department from a skilled nursing facility due to progressive lethargy over the past 3 days. The facility staff report that he has been refusing meals and liquids. On examination, temperature is 37.1°C (98.8°F), blood pressure is 98/60 mm Hg, pulse is 112/min, and respiratory rate is 16/min. The patient appears cachectic with profoundly dry mucous membranes and poor skin turgor. His current weight is 60 kg (132 lb).

Laboratory studies show:
Serum sodium: 168 mEq/L
Serum potassium: 4.1 mEq/L
Serum chloride: 129 mEq/L
Serum bicarbonate: 24 mEq/L
Blood urea nitrogen: 56 mg/dL
Serum creatinine: 1.8 mg/dL

Based on an estimated total body water of 50% of his body weight, what is this patient's calculated free water deficit in liters?

Cevabı ve açıklamayı göster

Cevap: 6

Cevap

6

The free water deficit is calculated using the formula:

Water\ Deficit = TBW \times \left(\frac{Actual\ Serum\ Na^+}{140} - 1\right)

. Given a weight of

60

kg and an estimated TBW fraction of

50\%

, the TBW is

30

L. The actual serum sodium is

168

mEq/L. Substituting these values into the formula yields:

30 \times \left(\frac{168}{140} - 1\right) = 30 \times (1.2 - 1) = 30 \times 0.2 = 6

liters. This represents the volume of solute-free water the patient has lost to develop this degree of hypernatremia.

Adım Adım Çözüm

1

Calculate the patient's Total Body Water (TBW).

TBW = 60 \times 0.50 = 30

L

Free water deficit calculations require an accurate estimate of the patient's baseline TBW, which is typically 50% of lean body weight for elderly men.

2

Set up the free water deficit formula.

Deficit = TBW \times \left(\frac{Actual\ [Na^+]}{Target\ [Na^+]} - 1\right)

This formula relates the current total body water to the proportional excess of sodium concentration relative to a normal target (140 mEq/L).

3

Substitute the calculated TBW and provided serum sodium values into the formula to find the final deficit.

Deficit = 30 \times \left(\frac{168}{140} - 1\right) = 30 \times (1.2 - 1) = 30 \times 0.2 = 6

L

This quantifies the exact volume of pure water required to dilute the current total body solute back to a normal serum sodium concentration of 140 mEq/L.

Anahtar Kavram

Free water deficit calculation in hypernatremia

Tahmini Süre:1m 30s

Soru 4497Soru →

A 65-year-old man with a history of chronic obstructive pulmonary disease (COPD) and type 2 diabetes mellitus is evaluated in the emergency department for progressive fatigue, shortness of breath, and lower extremity tingling over the past 4 weeks. He has not had fever, increased sputum production, or chest pain. Vital signs show a temperature of 37.0 C (98.6 F), blood pressure of 115/75 mmHg, pulse of 112/min, and respiratory rate of 22/min. Pulse oximetry is 94% on room air.

Physical examination reveals pale conjunctivae and a smooth, beefy red tongue. Neurologic examination shows decreased vibratory sensation in the lower extremities bilaterally. Lung auscultation is clear without wheezes or crackles. Heart exam reveals a 2/6 systolic ejection murmur at the left sternal border.

Laboratory results are as follows:

Test	Result	Reference Range
Hemoglobin	7.2 g/dL	13.5-17.5 g/dL
Mean corpuscular volume (MCV)	116 fL	80-100 fL
Leukocytes	3,100 /mm³	4,500-11,000 /mm³
Platelets	105,000 /mm³	150,000-400,000 /mm³
Sodium	138 mEq/L	136-145 mEq/L
Chloride	112 mEq/L	95-105 mEq/L
Bicarbonate	16 mEq/L	22-28 mEq/L
Blood urea nitrogen	18 mg/dL	7-18 mg/dL
Creatinine	0.9 mg/dL	0.6-1.2 mg/dL
TSH	2.1 µU/mL	0.5-5.0 µU/mL
Free T4	0.8 ng/dL	0.9-2.4 ng/dL

Arterial blood gas on room air shows pH 7.31, PaCO2 32 mmHg, and PaO2 75 mmHg. Peripheral blood smear reveals hypersegmented neutrophils and macro-ovalocytes. Blood cultures drawn 2 days ago in the outpatient clinic are negative.

Which of the following is the most appropriate next step in the management of this patient?

Measure serum vitamin B12 and methylmalonic acid levels

Administer inhaled albuterol and oral glucocorticoids

Start empirical intravenous vancomycin and cefepime

Initiate oral levothyroxine therapy

Administer intravenous sodium bicarbonate

Cevabı ve açıklamayı göster

Cevap: Measure serum vitamin B12 and methylmalonic acid levels

Cevap

Measure serum vitamin B12 and methylmalonic acid levels

The patient's presentation of macrocytic anemia (

MCV > 100

fL), pancytopenia, a smooth beefy red tongue (glossitis), and neurologic deficits (decreased vibratory sensation) is the classic manifestation of Vitamin B12 (cobalamin) deficiency. The neurologic symptoms, caused by subacute combined degeneration of the dorsal columns and lateral corticospinal tracts, are the key distinguishing feature from folate deficiency. The dyspnea and systolic flow murmur are secondary to the severe anemia. The most appropriate next step to confirm this diagnosis is measuring serum vitamin B12 and methylmalonic acid (MMA) levels. MMA is uniquely elevated in B12 deficiency because B12 is a required cofactor for the conversion of methylmalonyl-CoA to succinyl-CoA.

Adım Adım Çözüm

1

Analyze the clinical presentation and laboratory results.

The patient presents with progressive fatigue, dyspnea, macrocytic anemia (MCV 116 fL), pancytopenia, and decreased vibratory sensation.

To identify the primary pathophysiological process driving the patient's symptoms.

2

Correlate the hematologic findings with the neurologic exam.

Megaloblastic anemia combined with dorsal column signs (loss of vibratory sensation) strongly indicates Vitamin B12 (cobalamin) deficiency.

Folate deficiency causes identical hematologic changes but does not cause neurologic deficits.

3

Determine the most appropriate diagnostic test.

Measuring serum vitamin B12 and methylmalonic acid (MMA) levels is required to confirm the diagnosis.

MMA is elevated in B12 deficiency but normal in folate deficiency, providing definitive biochemical confirmation.

Anahtar Kavram

Vitamin B12 deficiency presents with megaloblastic anemia, pancytopenia, and neurologic deficits (subacute combined degeneration), and is definitively diagnosed by checking serum B12 and methylmalonic acid levels.

Tahmini Süre:1m 30s

Soru 4498Soru →

A 5-year-old boy is brought to the clinic by his parents for a routine health maintenance visit prior to starting kindergarten. He was born at 39 weeks gestation via uncomplicated spontaneous vaginal delivery. Vital signs include temperature 37.1°C (98.8°F), heart rate 95/min, and blood pressure 92/58 mm Hg. Physical examination reveals a cooperative, healthy-appearing child. His parents report that they recently immigrated, and his last well-child visit was at age 4 months. He is significantly behind on his immunizations, and a catch-up schedule is initiated today. The physician also reviews the boy's developmental history, and the parents recall his past progress clearly. Arrange the following developmental milestones in the expected chronological order of their acquisition in a normally developing child, from earliest to latest.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The milestones emerge chronologically as follows: Sitting without support (6 months), Utilizing a two-finger pincer grasp (12 months), Kicking a ball forward (2 years), Copying a circle (3 years), and Skipping on alternating feet (5 years).

Developmental milestones are evaluated during pediatric preventive care visits to ensure normal progression. The sequence begins in infancy with sitting without support (6 months), progresses to fine motor dexterity with a neat two-finger pincer grasp (12 months), advances to early toddler gross motor skills like kicking a ball (2 years), continues with fine motor coordination such as copying a circle (3 years), and culminates in advanced gross motor coordination like skipping (5 years).

Adım Adım Çözüm

1

Determine the age of expected acquisition for sitting without support.

6 months

Infants typically develop the core strength to sit up without propping by 6 months of age.

2

Determine the age of expected acquisition for utilizing a two-finger pincer grasp.

12 months

Fine motor skills progress from a raking grasp at 6 months to a neat, two-finger pincer grasp by 12 months.

3

Determine the age of expected acquisition for kicking a ball forward.

24 months (2 years)

Toddlers refine their balance and coordination to kick a ball and walk up stairs one step at a time by 2 years of age.

4

Determine the age of expected acquisition for copying a circle.

36 months (3 years)

Fine motor skills advance to drawing simple shapes, with a circle typically mastered at 3 years of age.

5

Determine the age of expected acquisition for skipping on alternating feet.

60 months (5 years)

Complex gross motor coordination, such as skipping and catching a bounced ball, is typically achieved by 5 years of age.

Anahtar Kavram

Normal pediatric developmental milestones follow a predictable chronological sequence and are evaluated alongside immunizations during well-child visits to identify any neurological or physical delays.

Soru 4499Soru →

Laboratory evaluation is performed during a routine follow-up visit for a 64-year-old man with a 15-year history of type 2 diabetes mellitus and hypertension. The patient reports feeling generally well and explicitly denies any recent nausea, vomiting, or diarrhea. His current medication regimen consists of metformin, lisinopril, amlodipine, and atorvastatin. Blood pressure is $134/82 \text{ mmHg}$ and pulse is $72/\text{min}$ .

Laboratory results are as follows:

Test	Result
Serum sodium	$137 \text{ mEq/L}$
Serum potassium	$5.9 \text{ mEq/L}$
Serum chloride	$110 \text{ mEq/L}$
Serum bicarbonate	$15 \text{ mEq/L}$
Blood urea nitrogen	$34 \text{ mg/dL}$
Serum creatinine	$1.8 \text{ mg/dL}$
Blood glucose	$142 \text{ mg/dL}$

Urinalysis reveals a pH of $5.2$ and is negative for glucose, ketones, and cellular casts.

Which of the following pathophysiologic mechanisms best explains this patient's current laboratory findings?

Reduced production of and distal tubular responsiveness to aldosterone

Failure of alpha-intercalated cells to secrete hydrogen ions

Impaired bicarbonate reabsorption in the proximal convoluted tubule

Accumulation of unmeasured endogenous acidic organic anions

Significant gastrointestinal loss of bicarbonate-rich secretions

Cevabı ve açıklamayı göster

Cevap: Reduced production of and distal tubular responsiveness to aldosterone

Cevap

Reduced production of and distal tubular responsiveness to aldosterone

This patient has a normal anion gap metabolic acidosis (Anion Gap = 137 - (110 + 15) = 12 mEq/L) accompanied by hyperkalemia. This pattern is pathognomonic for Type 4 Renal Tubular Acidosis (RTA). The most common etiology for Type 4 RTA in adults is hyporeninemic hypoaldosteronism due to diabetic nephropathy. Aldosterone normally functions to reabsorb sodium in exchange for potassium and hydrogen ion secretion in the distal tubule and collecting duct. A lack of aldosterone (or resistance to it) leads to retention of both potassium and hydrogen, causing hyperkalemic metabolic acidosis. The patient's use of lisinopril (an ACE inhibitor) further suppresses aldosterone synthesis, exacerbating the condition.

Adım Adım Çözüm

1

Calculate the serum anion gap.

Na^+ - (Cl^- + HCO_3^-) = 137 - (110 + 15) = 12 \text{ mEq/L}

.

To classify the metabolic acidosis as either normal anion gap or high anion gap. A gap of 12 is within the normal range.

2

Assess the serum potassium level in the context of the acid-base disorder.

The patient has hyperkalemia (

5.9 \text{ mEq/L}

) along with a normal anion gap metabolic acidosis (NAGMA).

Potassium levels help differentiate the causes of NAGMA. Diarrhea and Type 1/2 RTA present with hypokalemia, whereas Type 4 RTA presents with hyperkalemia.

3

Synthesize the clinical history and medication list.

The patient has longstanding diabetes mellitus and is taking lisinopril (an ACE inhibitor).

Diabetic nephropathy classically damages the juxtaglomerular apparatus, reducing renin secretion (hyporeninemic hypoaldosteronism). ACE inhibitors further decrease aldosterone levels, fully explaining the Type 4 RTA presentation.

Anahtar Kavram

Hyperkalemic normal anion gap metabolic acidosis (Type 4 RTA) is commonly caused by hyporeninemic hypoaldosteronism due to diabetic nephropathy and exacerbated by ACE inhibitors.

Tahmini Süre:1m 30s

Soru 4500Soru →

Match each patient's clinical presentation with the most likely predominant finding on their peripheral blood smear.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

Primary myelofibrosis pairs with teardrop cells; Chronic Lymphocytic Leukemia pairs with smudge cells; Thrombotic Thrombocytopenic Purpura pairs with schistocytes; and Beta-thalassemia trait pairs with target cells.

Each peripheral smear finding is classically linked to its corresponding clinical presentation: teardrop cells with bone marrow fibrosis, smudge cells with the fragile lymphocytes of CLL, schistocytes with the microvascular shearing of TTP, and target cells with the hemoglobinopathies like thalassemia.

Adım Adım Çözüm

1

Diagnose the underlying hematologic condition presented in each clinical vignette.

Patient 1 has primary myelofibrosis. Patient 2 has chronic lymphocytic leukemia (CLL). Patient 3 has thrombotic thrombocytopenic purpura (TTP). Patient 4 has beta-thalassemia trait.

Recognizing the disease based on clinical and laboratory clues is required to anticipate the peripheral smear findings.

2

Identify the pathognomonic or highly characteristic peripheral blood smear findings associated with each diagnosed condition.

Myelofibrosis features teardrop cells. CLL features smudge cells. TTP features schistocytes. Thalassemia features target cells.

Red blood cell and white blood cell morphology provide critical diagnostic confirmation for these respective diseases.

Anahtar Kavram

Pathognomonic peripheral blood smear findings in hematologic disorders

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram